Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	G protein-coupled receptor activity	OR51T1 OR2L8 DRD2 DRD3 OR2B2 HTR6 GPR32 GPR42 OR10J6P MRGPRE OR2L5 OR10Q1 ADGRB2 OR8H1 OR2H1 GRM3 OR10T2 CHRM3 OR10R2 OR14A16 OR2L2 OPRPN ADORA2B OR10AG1 ADRA2C LPAR6 SMO OR4K5 TAS2R31 OR10S1 OR4K3 OR4K15 GPR119	1.28e-15	884	139	33	GO:0004930
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	OR51T1 OR2L8 DRD2 DRD3 OR2B2 EPHA6 HTR6 GPR32 GPR42 OR10J6P MRGPRE OR2L5 OR10Q1 ADGRB2 OR8H1 OR2H1 GRM3 OR10T2 CHRM3 OR10R2 OR14A16 OR2L2 OPRPN ADORA2B LIFR OR10AG1 ADRA2C LPAR6 SMO OR4K5 TAS2R31 OR10S1 OR4K3 OR4K15 GPR119	7.26e-12	1353	139	35	GO:0004888
GeneOntologyMolecularFunction	olfactory receptor activity	OR51T1 OR2L8 OR2B2 OR10J6P OR2L5 OR10Q1 OR8H1 OR2H1 OR10T2 OR10R2 OR14A16 OR2L2 OR10AG1 OR4K5 OR10S1 OR4K3 OR4K15	8.60e-09	431	139	17	GO:0004984
GeneOntologyMolecularFunction	transporter activity	CACNA1D TMEM30B SPNS1 ABCC4 SLC16A9 SLC2A8 PIEZO1 COX8A ATP9B PKD1L2 SLC30A3 SLC7A11 SLC18B1 SLC66A1 CACNG3 SLC22A18 SLC15A2 KCNJ6 NPC1L1 ABCB11 SLC45A2 TMC5 SLC24A1 SLC23A2 SLC4A5 MFSD10	8.05e-07	1289	139	26	GO:0005215
GeneOntologyMolecularFunction	active transmembrane transporter activity	ABCC4 SLC16A9 SLC2A8 COX8A SLC30A3 SLC7A11 SLC18B1 SLC22A18 SLC15A2 ABCB11 SLC45A2 SLC24A1 SLC23A2 SLC4A5	6.26e-06	477	139	14	GO:0022804
GeneOntologyMolecularFunction	transmembrane transporter activity	CACNA1D SPNS1 ABCC4 SLC16A9 SLC2A8 PIEZO1 COX8A PKD1L2 SLC30A3 SLC7A11 SLC18B1 SLC66A1 CACNG3 SLC22A18 SLC15A2 KCNJ6 ABCB11 SLC45A2 TMC5 SLC24A1 SLC23A2 SLC4A5 MFSD10	6.74e-06	1180	139	23	GO:0022857
GeneOntologyMolecularFunction	secondary active transmembrane transporter activity	SLC16A9 SLC2A8 SLC30A3 SLC7A11 SLC18B1 SLC22A18 SLC15A2 SLC45A2 SLC24A1 SLC23A2 SLC4A5	7.34e-06	296	139	11	GO:0015291
GeneOntologyMolecularFunction	organic anion transmembrane transporter activity	ABCC4 SLC16A9 SLC2A8 SLC7A11 SLC66A1 SLC22A18 ABCB11 SLC23A2 SLC4A5 MFSD10	4.00e-05	293	139	10	GO:0008514
GeneOntologyMolecularFunction	symporter activity	SLC16A9 SLC22A18 SLC15A2 SLC45A2 SLC24A1 SLC23A2 SLC4A5	8.75e-05	150	139	7	GO:0015293
GeneOntologyMolecularFunction	dopamine neurotransmitter receptor activity, coupled via Gi/Go	DRD2 DRD3	1.44e-04	3	139	2	GO:0001591
GeneOntologyMolecularFunction	carbohydrate transmembrane transporter activity	SLC2A8 ABCB11 SLC45A2 SLC23A2	2.05e-04	42	139	4	GO:0015144
GeneOntologyMolecularFunction	ABC-type bile acid transporter activity	ABCC4 ABCB11	2.86e-04	4	139	2	GO:0015432
GeneOntologyMolecularFunction	ATPase-coupled organic acid transmembrane transporter activity	ABCC4 ABCB11	2.86e-04	4	139	2	GO:0033283
GeneOntologyMolecularFunction	ATPase-coupled monocarboxylic acid transmembrane transporter activity	ABCC4 ABCB11	2.86e-04	4	139	2	GO:0033285
GeneOntologyMolecularFunction	ATPase-coupled carboxylic acid transmembrane transporter activity	ABCC4 ABCB11	2.86e-04	4	139	2	GO:0033284
GeneOntologyMolecularFunction	dopamine neurotransmitter receptor activity	DRD2 DRD3	4.75e-04	5	139	2	GO:0004952
GeneOntologyMolecularFunction	monoatomic cation transmembrane transporter activity	CACNA1D PIEZO1 COX8A PKD1L2 SLC30A3 SLC18B1 CACNG3 SLC15A2 KCNJ6 SLC45A2 SLC24A1 SLC23A2 SLC4A5	7.58e-04	664	139	13	GO:0008324
GeneOntologyMolecularFunction	monosaccharide transmembrane transporter activity	SLC2A8 SLC45A2 SLC23A2	8.54e-04	27	139	3	GO:0015145
GeneOntologyMolecularFunction	sugar transmembrane transporter activity	SLC2A8 SLC45A2 SLC23A2	1.06e-03	29	139	3	GO:0051119
GeneOntologyMolecularFunction	monoatomic ion transmembrane transporter activity	CACNA1D PIEZO1 COX8A PKD1L2 SLC30A3 SLC18B1 CACNG3 SLC15A2 KCNJ6 SLC45A2 TMC5 SLC24A1 SLC23A2 SLC4A5	1.29e-03	793	139	14	GO:0015075
GeneOntologyMolecularFunction	alcohol transmembrane transporter activity	ABCC4 MFSD10	1.31e-03	8	139	2	GO:0015665
GeneOntologyMolecularFunction	inorganic cation transmembrane transporter activity	CACNA1D COX8A PKD1L2 SLC30A3 SLC18B1 CACNG3 SLC15A2 KCNJ6 SLC45A2 SLC24A1 SLC23A2 SLC4A5	1.47e-03	627	139	12	GO:0022890
GeneOntologyMolecularFunction	modified amino acid transmembrane transporter activity	ABCC4 SLC16A9 SLC7A11	1.55e-03	33	139	3	GO:0072349
GeneOntologyMolecularFunction	tripeptide transmembrane transporter activity	ABCC4 SLC15A2	1.68e-03	9	139	2	GO:0042937
GeneOntologyMolecularFunction	ATPase-coupled lipid transmembrane transporter activity	ABCC4 ABCB11	1.68e-03	9	139	2	GO:0034040
GeneOntologyMolecularFunction	xenobiotic transmembrane transporter activity	ABCC4 SLC22A18 ABCB11	1.69e-03	34	139	3	GO:0042910
GeneOntologyMolecularFunction	odorant binding	OR10Q1 OR8H1 OR10T2 OR10R2 OR14A16	1.96e-03	127	139	5	GO:0005549
GeneOntologyMolecularFunction	inorganic molecular entity transmembrane transporter activity	CACNA1D ABCC4 COX8A PKD1L2 SLC30A3 SLC18B1 CACNG3 SLC15A2 KCNJ6 SLC45A2 SLC24A1 SLC23A2 SLC4A5	2.47e-03	758	139	13	GO:0015318
GeneOntologyBiologicalProcess	G protein-coupled receptor signaling pathway	OR51T1 CACNA1D OR2L8 DRD2 DRD3 OR2B2 HTR6 GPR32 GPR42 OR10J6P MRGPRE OR2L5 OR10Q1 ADGRB2 OR8H1 DGKH OR2H1 GRM3 OR10T2 CHRM3 OR10R2 OR14A16 OR2L2 OPRPN ADORA2B OR10AG1 ADRA2C LPAR6 SMO OR4K5 TAS2R31 OR10S1 OR4K3 OR4K15 GPR119	5.55e-12	1395	138	35	GO:0007186
GeneOntologyBiologicalProcess	detection of stimulus	OR51T1 OR2L8 OR2B2 OR10J6P PIEZO1 OR2L5 OR10Q1 NAIP OR8H1 TLR9 OR2H1 PKD1L2 OR10T2 OR10R2 OR14A16 OR2L2 OR10AG1 LPO SMO OR4K5 TAS2R31 OR10S1 OR4K3 OR4K15	8.00e-11	722	138	24	GO:0051606
GeneOntologyBiologicalProcess	detection of chemical stimulus	OR51T1 OR2L8 OR2B2 OR10J6P OR2L5 OR10Q1 OR8H1 TLR9 OR2H1 OR10T2 OR10R2 OR14A16 OR2L2 OR10AG1 LPO OR4K5 TAS2R31 OR10S1 OR4K3 OR4K15	3.30e-10	524	138	20	GO:0009593
GeneOntologyBiologicalProcess	detection of chemical stimulus involved in sensory perception	OR51T1 OR2L8 OR2B2 OR10J6P OR2L5 OR10Q1 OR8H1 OR2H1 OR10T2 OR10R2 OR14A16 OR2L2 OR10AG1 LPO OR4K5 TAS2R31 OR10S1 OR4K3 OR4K15	6.18e-10	485	138	19	GO:0050907
GeneOntologyBiologicalProcess	sensory perception of chemical stimulus	OR51T1 OR2L8 DRD2 OR2B2 OR10J6P OR2L5 OR10Q1 OR8H1 OR2H1 OR10T2 OR10R2 OR14A16 OR2L2 OR10AG1 LPO OR4K5 TAS2R31 OR10S1 OR4K3 OR4K15	6.97e-10	547	138	20	GO:0007606
GeneOntologyBiologicalProcess	sensory perception	OR51T1 CACNA1D OR2L8 DRD2 OR2B2 OR10J6P OR2L5 OR10Q1 OR8H1 OR2H1 GRM3 OR10T2 OR10R2 OR14A16 SPX OR2L2 OPRPN OR10AG1 LPO SLC45A2 OR4K5 TAS2R31 OR10S1 SLC24A1 OR4K3 OR4K15 OTOG	2.15e-09	1072	138	27	GO:0007600
GeneOntologyBiologicalProcess	sensory perception of smell	OR51T1 OR2L8 DRD2 OR2B2 OR10J6P OR2L5 OR10Q1 OR8H1 OR2H1 OR10T2 OR10R2 OR14A16 OR2L2 OR10AG1 OR4K5 OR10S1 OR4K3 OR4K15	2.19e-09	465	138	18	GO:0007608
GeneOntologyBiologicalProcess	detection of chemical stimulus involved in sensory perception of smell	OR51T1 OR2L8 OR2B2 OR10J6P OR2L5 OR10Q1 OR8H1 OR2H1 OR10T2 OR10R2 OR14A16 OR2L2 OR10AG1 OR4K5 OR10S1 OR4K3 OR4K15	4.96e-09	432	138	17	GO:0050911
GeneOntologyBiologicalProcess	detection of stimulus involved in sensory perception	OR51T1 OR2L8 OR2B2 OR10J6P OR2L5 OR10Q1 OR8H1 OR2H1 OR10T2 OR10R2 OR14A16 OR2L2 OR10AG1 LPO OR4K5 TAS2R31 OR10S1 OR4K3 OR4K15	1.22e-08	582	138	19	GO:0050906
GeneOntologyBiologicalProcess	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	CACNA1D DRD2 DRD3 HTR6 GPR42 ADGRB2 GRM3 CHRM3 ADORA2B ADRA2C GPR119	3.64e-06	286	138	11	GO:0007188
GeneOntologyBiologicalProcess	regulation of catecholamine secretion	DRD2 DRD3 HTR6 GPR42 ADORA2B ADRA2C	5.74e-06	67	138	6	GO:0050433
GeneOntologyBiologicalProcess	organic cation transport	SLC16A9 HTR6 GPR42 SLC18B1 SLC66A1 ADORA2B SLC22A18 ADRA2C	6.04e-06	145	138	8	GO:0015695
GeneOntologyBiologicalProcess	monoamine transport	DRD2 DRD3 HTR6 GPR42 SLC18B1 ADORA2B ADRA2C	1.31e-05	116	138	7	GO:0015844
GeneOntologyBiologicalProcess	catecholamine secretion	DRD2 DRD3 HTR6 GPR42 ADORA2B ADRA2C	1.50e-05	79	138	6	GO:0050432
GeneOntologyBiologicalProcess	organic hydroxy compound transport	ABCC4 DRD2 DRD3 HTR6 GPR42 SLC18B1 ADORA2B ADRA2C NPC1L1 ABCB11 MFSD10	2.98e-05	358	138	11	GO:0015850
GeneOntologyBiologicalProcess	tripeptide transmembrane transport	ABCC4 SLC7A11 SLC15A2	3.40e-05	10	138	3	GO:0035443
GeneOntologyBiologicalProcess	organic anion transport	ABCC4 DRD2 DRD3 SLC16A9 HTR6 SLC2A8 SLC7A11 SLC66A1 SPX ABCB11 SLC23A2 SLC4A5 MFSD10	4.34e-05	515	138	13	GO:0015711
GeneOntologyBiologicalProcess	catecholamine transport	DRD2 DRD3 HTR6 GPR42 ADORA2B ADRA2C	4.55e-05	96	138	6	GO:0051937
GeneOntologyBiologicalProcess	regulation of adenylate cyclase activity	CACNA1D DRD2 DRD3 GRM3 ADORA2B	4.67e-05	59	138	5	GO:0045761
GeneOntologyBiologicalProcess	tripeptide transport	ABCC4 SLC7A11 SLC15A2	7.98e-05	13	138	3	GO:0042939
GeneOntologyBiologicalProcess	regulation of cyclase activity	CACNA1D DRD2 DRD3 GRM3 ADORA2B	9.94e-05	69	138	5	GO:0031279
GeneOntologyBiologicalProcess	regulation of lyase activity	CACNA1D DRD2 DRD3 GRM3 ADORA2B	1.30e-04	73	138	5	GO:0051339
GeneOntologyBiologicalProcess	oligopeptide transmembrane transport	ABCC4 SLC7A11 SLC15A2	1.86e-04	17	138	3	GO:0035672
GeneOntologyBiologicalProcess	regulation of amine transport	DRD2 DRD3 HTR6 GPR42 ADORA2B ADRA2C	1.97e-04	125	138	6	GO:0051952
GeneOntologyBiologicalProcess	negative regulation of adenylate cyclase activity	DRD2 DRD3 GRM3	2.22e-04	18	138	3	GO:0007194
GeneOntologyBiologicalProcess	negative regulation of cyclase activity	DRD2 DRD3 GRM3	2.63e-04	19	138	3	GO:0031280
GeneOntologyBiologicalProcess	negative regulation of dopamine receptor signaling pathway	DRD2 DRD3	2.64e-04	4	138	2	GO:0060160
GeneOntologyBiologicalProcess	phospholipase C-activating G protein-coupled receptor signaling pathway	DRD2 DRD3 GPR32 CHRM3 OPRPN LPAR6	2.75e-04	133	138	6	GO:0007200
GeneOntologyBiologicalProcess	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	DRD2 DRD3 GPR42 GRM3 CHRM3	2.81e-04	86	138	5	GO:0007193
GeneOntologyBiologicalProcess	amine transport	DRD2 DRD3 HTR6 GPR42 ADORA2B ADRA2C	3.23e-04	137	138	6	GO:0015837
GeneOntologyBiologicalProcess	phenol-containing compound metabolic process	DRD2 DRD3 SLC7A11 KCNJ6 DIO3 SLC45A2	3.91e-04	142	138	6	GO:0018958
GeneOntologyBiologicalProcess	negative regulation of lyase activity	DRD2 DRD3 GRM3	4.11e-04	22	138	3	GO:0051350
GeneOntologyBiologicalProcess	oligopeptide import across plasma membrane	SLC7A11 SLC15A2	4.39e-04	5	138	2	GO:0140205
GeneOntologyBiologicalProcess	dipeptide import across plasma membrane	SLC7A11 SLC15A2	4.39e-04	5	138	2	GO:0140206
GeneOntologyBiologicalProcess	carboxylic acid transport	ABCC4 DRD2 DRD3 SLC16A9 HTR6 SLC7A11 SLC66A1 SPX ABCB11 SLC23A2	4.46e-04	410	138	10	GO:0046942
GeneOntologyBiologicalProcess	organic acid transport	ABCC4 DRD2 DRD3 SLC16A9 HTR6 SLC7A11 SLC66A1 SPX ABCB11 SLC23A2	4.63e-04	412	138	10	GO:0015849
GeneOntologyBiologicalProcess	oligopeptide transport	ABCC4 SLC7A11 SLC15A2	4.70e-04	23	138	3	GO:0006857
GeneOntologyBiologicalProcess	regulation of sensory perception of pain	GRM3 SPX OPRPN	4.70e-04	23	138	3	GO:0051930
GeneOntologyBiologicalProcess	regulation of sensory perception	GRM3 SPX OPRPN	5.35e-04	24	138	3	GO:0051931
GeneOntologyBiologicalProcess	acid secretion	DRD2 DRD3 HTR6 ABCB11	5.76e-04	57	138	4	GO:0046717
GeneOntologyBiologicalProcess	adenylate cyclase-activating adrenergic receptor signaling pathway	DRD2 DRD3 ADRA2C	6.05e-04	25	138	3	GO:0071880
GeneOntologyBiologicalProcess	adenylate cyclase-inhibiting dopamine receptor signaling pathway	DRD2 DRD3	6.55e-04	6	138	2	GO:0007195
GeneOntologyBiologicalProcess	regulation of norepinephrine secretion	GPR42 ADORA2B ADRA2C	6.81e-04	26	138	3	GO:0014061
GeneOntologyBiologicalProcess	norepinephrine secretion	GPR42 ADORA2B ADRA2C	8.49e-04	28	138	3	GO:0048243
GeneOntologyBiologicalProcess	xenobiotic transport	ABCC4 SLC22A18 SLC15A2 ABCB11	8.93e-04	64	138	4	GO:0042908
Domain	7tm_1	OR51T1 OR2L8 DRD2 DRD3 OR2B2 HTR6 GPR32 GPR42 MRGPRE OR2L5 OR10Q1 OR8H1 OR2H1 OR10T2 CHRM3 OR10R2 OR14A16 OR2L2 ADORA2B OR10AG1 ADRA2C LPAR6 OR4K5 OR10S1 OR4K15 GPR119	4.11e-12	677	138	26	PF00001
Domain	G_PROTEIN_RECEP_F1_1	OR51T1 OR2L8 DRD2 DRD3 OR2B2 HTR6 GPR32 GPR42 MRGPRE OR2L5 OR10Q1 OR8H1 OR2H1 OR10T2 CHRM3 OR10R2 OR14A16 OR2L2 ADORA2B OR10AG1 ADRA2C LPAR6 OR4K5 OR10S1 OR4K15 GPR119	5.35e-12	685	138	26	PS00237
Domain	G_PROTEIN_RECEP_F1_2	OR51T1 OR2L8 DRD2 DRD3 OR2B2 HTR6 GPR32 GPR42 MRGPRE OR2L5 OR10Q1 OR8H1 OR2H1 OR10T2 CHRM3 OR10R2 OR14A16 OR2L2 ADORA2B OR10AG1 ADRA2C LPAR6 OR4K5 OR10S1 OR4K15 GPR119	6.50e-12	691	138	26	PS50262
Domain	GPCR_Rhodpsn	OR51T1 OR2L8 DRD2 DRD3 OR2B2 HTR6 GPR32 GPR42 MRGPRE OR2L5 OR10Q1 OR8H1 OR2H1 OR10T2 CHRM3 OR10R2 OR14A16 OR2L2 ADORA2B OR10AG1 ADRA2C LPAR6 OR4K5 OR10S1 OR4K15 GPR119	6.71e-12	692	138	26	IPR000276
Domain	GPCR_Rhodpsn_7TM	OR51T1 OR2L8 DRD2 DRD3 OR2B2 HTR6 GPR32 MRGPRE OR2L5 OR10Q1 OR8H1 OR2H1 OR10T2 CHRM3 OR10R2 OR14A16 OR2L2 ADORA2B OR10AG1 ADRA2C LPAR6 OR4K5 OR10S1 OR4K15 GPR119	2.09e-11	670	138	25	IPR017452
Domain	Olfact_rcpt	OR51T1 OR2L8 OR2B2 OR2L5 OR10Q1 OR8H1 OR2H1 OR10T2 OR10R2 OR14A16 OR2L2 OR10AG1 OR4K5 OR10S1 OR4K15	2.23e-07	393	138	15	IPR000725
Domain	MFS_dom	SPNS1 SLC16A9 SLC2A8 SLC18B1 SLC22A18 SLC15A2 SLC45A2 MFSD10	6.91e-06	134	138	8	IPR020846
Domain	MFS_1	SPNS1 SLC16A9 SLC18B1 SLC22A18 SLC45A2 MFSD10	2.25e-05	77	138	6	PF07690
Domain	MFS	SPNS1 SLC16A9 SLC18B1 SLC22A18 SLC45A2 MFSD10	2.25e-05	77	138	6	IPR011701
Domain	MFS	SPNS1 SLC16A9 SLC2A8 SLC18B1 SLC22A18 MFSD10	1.51e-04	108	138	6	PS50850
Domain	7TM_GPCR_Srsx	DRD2 DRD3 HTR6 CHRM3 ADORA2B ADRA2C	1.84e-04	112	138	6	SM01381
Domain	HEAT	STK36 TNPO2 HEATR1 UTP20	4.31e-04	48	138	4	PF02985
Domain	Dopamine_rcpt	DRD2 DRD3	5.34e-04	5	138	2	IPR000929
Pathway	REACTOME_SENSORY_PERCEPTION	OR51T1 CACNA1D OR2L8 OR2B2 OR2L5 OR10Q1 OR8H1 OR2H1 OR10T2 OR10R2 OR14A16 OR2L2 OR10AG1 OR4K5 TAS2R31 OR10S1 SLC24A1 OR4K3 OR4K15 OTOG	1.14e-08	636	98	20	M41834
Pathway	REACTOME_OLFACTORY_SIGNALING_PATHWAY	OR51T1 OR2L8 OR2B2 OR2L5 OR10Q1 OR8H1 OR2H1 OR10T2 OR10R2 OR14A16 OR2L2 OR10AG1 OR4K5 OR10S1 OR4K3 OR4K15	2.65e-08	417	98	16	M4072
Pathway	WP_GPCRS_NONODORANT	DRD2 DRD3 HTR6 GPR42 ADGRB2 GRM3 CHRM3 OPRPN ADORA2B ADRA2C LPAR6 SMO GPR119	3.70e-08	266	98	13	MM15843
Pathway	KEGG_OLFACTORY_TRANSDUCTION	OR51T1 OR2L8 OR2B2 OR10Q1 OR8H1 OR2H1 OR10T2 OR10R2 OR14A16 OR2L2 OR10AG1 OR4K5 OR10S1 OR4K15	4.67e-07	389	98	14	M14091
Pathway	WP_GPCRS_CLASS_A_RHODOPSINLIKE	DRD2 DRD3 OR2B2 HTR6 GPR32 GPR42 OR2H1 CHRM3 ADORA2B ADRA2C LPAR6	1.85e-06	260	98	11	M39397
Pathway	WP_MONOAMINE_GPCRS	DRD2 DRD3 HTR6 CHRM3 ADRA2C	2.16e-06	31	98	5	MM15871
Pathway	WP_MONOAMINE_GPCRS	DRD2 DRD3 HTR6 CHRM3 ADRA2C	2.98e-06	33	98	5	M39585
Pathway	REACTOME_AMINE_LIGAND_BINDING_RECEPTORS	DRD2 DRD3 HTR6 CHRM3 ADRA2C	1.02e-05	42	98	5	M5868
Pathway	REACTOME_AMINE_LIGAND_BINDING_RECEPTORS	DRD2 DRD3 HTR6 CHRM3 ADRA2C	1.02e-05	42	98	5	MM14971
Pathway	REACTOME_GPCR_LIGAND_BINDING	DRD2 DRD3 HTR6 GPR42 GRM3 CHRM3 OPRPN ADORA2B ADRA2C LPAR6 TAS2R31	1.93e-04	430	98	11	MM15160
Pathway	REACTOME_DOPAMINE_RECEPTORS	DRD2 DRD3	4.72e-04	5	98	2	M27301
Pathway	REACTOME_DOPAMINE_RECEPTORS	DRD2 DRD3	4.72e-04	5	98	2	MM15007
Pathway	REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS	DRD2 DRD3 HTR6 GPR42 CHRM3 OPRPN ADORA2B ADRA2C LPAR6	5.11e-04	333	98	9	MM14963
Pathway	KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	DRD2 DRD3 HTR6 GRM3 CHRM3 ADORA2B ADRA2C LPAR6	6.09e-04	272	98	8	M13380
Pubmed	The human olfactory receptor gene family.	OR51T1 OR2L8 OR2B2 OR10J6P OR2L5 OR10Q1 OR8H1 OR2H1 OR10T2 OR10R2 OR14A16 OR2L2 OR10AG1 OR4K5 OR10S1 OR4K3 OR4K15	1.07e-10	541	143	17	14983052
Pubmed	Different evolutionary processes shaped the mouse and human olfactory receptor gene families.	OR51T1 OR2L8 OR2B2 OR2L5 OR10Q1 OR8H1 OR2H1 OR2L2 OR10AG1 OR4K5 OR10S1 OR4K15	1.90e-08	340	143	12	11875048
Pubmed	The olfactory receptor gene superfamily of the mouse.	OR51T1 OR2L8 OR2B2 OR2L5 OR10Q1 OR8H1 OR2H1 OR2L2 OR10AG1 OR4K5 OR10S1 OR4K15	1.90e-08	340	143	12	11802173
Pubmed	A unified nomenclature for vertebrate olfactory receptors.	OR51T1 OR2L8 OR2B2 OR2L5 OR10Q1 OR8H1 OR2H1 OR2L2 OR10AG1 OR4K5 OR10S1 OR4K15	2.09e-08	343	143	12	32295537
Pubmed	Odorant receptor expressed sequence tags demonstrate olfactory expression of over 400 genes, extensive alternate splicing and unequal expression levels.	OR51T1 OR2L8 OR2B2 OR2L5 OR10Q1 OR8H1 OR2H1 OR2L2 OR10AG1 OR4K5 OR10S1 OR4K15	2.30e-08	346	143	12	14611657
Pubmed	Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: sibling analysis and proband follow-up.	DRD2 DRD3 GRM3 CHRM3 ADRA2C	1.17e-06	45	143	5	21041608
Pubmed	Spatiotemporal regulation of GLI target genes in the mammalian limb bud.	TMEM30B DRD3 PKDCC OR2H1 SLC66A1 TMTC1 SMO SPARCL1	2.46e-06	207	143	8	26238476
Pubmed	Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions.	DRD2 DRD3 HTR6	3.75e-06	8	143	3	19997080
Pubmed	Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome.	DRD2 DRD3 HTR6	3.75e-06	8	143	3	19636338
Pubmed	N-linked Glycosylation on the N-terminus of the dopamine D2 and D3 receptors determines receptor association with specific microdomains in the plasma membrane.	DRD2 DRD3	1.68e-05	2	143	2	25289757
Pubmed	Toward predicting drug-induced liver injury: parallel computational approaches to identify multidrug resistance protein 4 and bile salt export pump inhibitors.	ABCC4 ABCB11	1.68e-05	2	143	2	25735837
Pubmed	Dopamine receptor D2 and D3 gene variants are not associated with the antidepressant effect of total sleep deprivation in bipolar depression.	DRD2 DRD3	1.68e-05	2	143	2	12834818
Pubmed	Mapping the landscape of human dopamine D2/3 receptors with [11C]raclopride.	DRD2 DRD3	1.68e-05	2	143	2	31444615
Pubmed	Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation.	DRD2 DRD3	1.68e-05	2	143	2	22970199
Pubmed	Association of novelty seeking scores and striatal dopamine D₂/D₃ receptor availability of healthy volunteers: single photon emission computed tomography with ¹²³i-iodobenzamide.	DRD2 DRD3	1.68e-05	2	143	2	20970071
Pubmed	Palmitoylation on the carboxyl terminus tail is required for the selective regulation of dopamine D2 versus D3 receptors.	DRD2 DRD3	1.68e-05	2	143	2	27349735
Pubmed	Association study of dopamine D2, D3 receptor gene polymorphisms with motor fluctuations in PD.	DRD2 DRD3	1.68e-05	2	143	2	11425949
Pubmed	Cortical dopamine D2/D3 receptors and verbal memory in man.	DRD2 DRD3	1.68e-05	2	143	2	20188195
Pubmed	DRD3 (dopamine receptor D3) but not DRD2 activates autophagy through MTORC1 inhibition preserving protein synthesis.	DRD2 DRD3	1.68e-05	2	143	2	31538542
Pubmed	Striatal dopamine D₂/D₃ receptor binding in pathological gambling is correlated with mood-related impulsivity.	DRD2 DRD3	1.68e-05	2	143	2	22776462
Pubmed	Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients.	DRD2 DRD3	1.68e-05	2	143	2	16959057
Pubmed	Fluorescent ligands for dopamine D2/D3 receptors.	DRD2 DRD3	1.68e-05	2	143	2	33318558
Pubmed	[123I]epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable: implications for the use of cerebellum as a reference region.	DRD2 DRD3	1.68e-05	2	143	2	17175177
Pubmed	Dopamine D2 (DAD2) and dopamine D3 (DAD3) receptor gene polymorphisms and treatment outcome in alcohol dependence.	DRD2 DRD3	1.68e-05	2	143	2	12811641
Pubmed	Association Study Between DRD2, DRD3 Genetic Polymorphisms and Adverse Reactions in Chinese Patients on Amisulpride Treatment.	DRD2 DRD3	1.68e-05	2	143	2	39187246
Pubmed	Dopamine D2/3 Binding Potential Modulates Neural Signatures of Working Memory in a Load-Dependent Fashion.	DRD2 DRD3	1.68e-05	2	143	2	30478031
Pubmed	Association study of dopamine D2 and D3 receptor gene polymorphisms with cocaine dependence.	DRD2 DRD3	1.68e-05	2	143	2	16094250
Pubmed	Extrastriatal dopamine D 2/3 receptor density and distribution in drug-naive schizophrenic patients.	DRD2 DRD3	1.68e-05	2	143	2	12740603
Pubmed	Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone).	DRD2 DRD3	1.68e-05	2	143	2	19011428
Pubmed	Mice lacking dopamine D2 and D3 receptors exhibit differential activation of prefrontal cortical neurons during tasks requiring attention.	DRD2 DRD3	1.68e-05	2	143	2	15537671
Pubmed	Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium.	DRD2 DRD3	1.68e-05	2	143	2	21663922
Pubmed	Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.	DRD2 DRD3	1.68e-05	2	143	2	26819282
Pubmed	Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson's disease patients.	DRD2 DRD3	1.68e-05	2	143	2	19396436
Pubmed	Dopamine D2/3 receptor availability and amphetamine-induced dopamine release in obesity.	DRD2 DRD3	1.68e-05	2	143	2	24785761
Pubmed	Potentiation of the D2 mutant motor phenotype in mice lacking dopamine D2 and D3 receptors.	DRD2 DRD3	1.68e-05	2	143	2	10391470
Pubmed	Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson's disease.	DRD2 DRD3	1.68e-05	2	143	2	19669131
Pubmed	Elevation of dopamine induced by cigarette smoking: novel insights from a [11C]-+-PHNO PET study in humans.	DRD2 DRD3	1.68e-05	2	143	2	23954846
Pubmed	Latent-Profile Analysis Reveals Behavioral and Brain Correlates of Dopamine-Cognition Associations.	DRD2 DRD3	1.68e-05	2	143	2	29028935
Pubmed	Positive association of dopamine D2 receptor polymorphism with bipolar affective disorder in a European Multicenter Association Study of affective disorders.	DRD2 DRD3	1.68e-05	2	143	2	11857579
Pubmed	Functional homomers and heteromers of dopamine D2L and D3 receptors co-exist at the cell surface.	DRD2 DRD3	1.68e-05	2	143	2	22291025
Pubmed	Relationship of frontal D(2/3) binding potentials to cognition: a study of antipsychotic-naive schizophrenia patients.	DRD2 DRD3	1.68e-05	2	143	2	22338593
Pubmed	[¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.	DRD2 DRD3	1.68e-05	2	143	2	25641350
Pubmed	Neurons exhibiting dopamine D2 receptor immunoreactivity in the substantia nigra of the mutant weaver mouse.	DRD2 KCNJ6	1.68e-05	2	143	2	10051229
Pubmed	Postnatal ontogeny of dopamine D3 receptors in the mouse brain: autoradiographic evidence for a transient cortical expression.	DRD2 DRD3	1.68e-05	2	143	2	8836575
Pubmed	A shared spatial topography links the functional connectome correlates of cocaine use disorder and dopamine D2/3 receptor densities.	DRD2 DRD3	1.68e-05	2	143	2	39300138
Pubmed	Striatal dopamine D2/3 receptor availability increases after long-term bariatric surgery-induced weight loss.	DRD2 DRD3	1.68e-05	2	143	2	27184782
Pubmed	Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa.	DRD2 DRD3	1.68e-05	2	143	2	23154100
Pubmed	Variability in Action Selection Relates to Striatal Dopamine 2/3 Receptor Availability in Humans: A PET Neuroimaging Study Using Reinforcement Learning and Active Inference Models.	DRD2 DRD3	1.68e-05	2	143	2	32083297
Pubmed	Posterior dopamine D2/3 receptors and brain network functional connectivity.	DRD2 DRD3	1.68e-05	2	143	2	28700819
Pubmed	Decreased c-fos responses to dopamine D(1) receptor agonist stimulation in mice deficient for D(3) receptors.	DRD2 DRD3	1.68e-05	2	143	2	10506202
Pubmed	DRD2/ANKK1 Taq1A polymorphism (rs1800497) has opposing effects on D2/3 receptor binding in healthy controls and patients with major depressive disorder.	DRD2 DRD3	1.68e-05	2	143	2	23683269
Pubmed	Effects of the DRD3 Ser9Gly polymorphism on aripiprazole efficacy in schizophrenic patients as modified by clinical factors.	DRD2 DRD3	1.68e-05	2	143	2	19302829
Pubmed	Cerebral morphology and dopamine D2/D3 receptor distribution in humans: a combined [18F]fallypride and voxel-based morphometry study.	DRD2 DRD3	1.68e-05	2	143	2	19457373
Pubmed	Signaling pathways leading to phosphorylation of Akt and GSK-3β by activation of cloned human and rat cerebral D₂and D₃ receptors.	DRD2 DRD3	1.68e-05	2	143	2	20952497
Pubmed	G protein coupling and ligand selectivity of the D2L and D3 dopamine receptors.	DRD2 DRD3	1.68e-05	2	143	2	18218829
Pubmed	Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation.	DRD2 DRD3	1.68e-05	2	143	2	18410503
Pubmed	Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake.	DRD2 DRD3	1.68e-05	2	143	2	25511804
Pubmed	Dopamine D2 receptors preferentially regulate the development of light responses of the inner retina.	DRD2 DRD3	1.68e-05	2	143	2	25393815
Pubmed	The dopamine D2 receptors in high-affinity state and D3 receptors in schizophrenia: a clinical [11C]-(+)-PHNO PET study.	DRD2 DRD3	1.68e-05	2	143	2	18987627
Pubmed	Roles of conserved intracellular sequences regions for the proper expression of dopamine D(2) and D(3) receptors.	DRD2 DRD3	1.68e-05	2	143	2	18481021
Pubmed	The candidate gene approach in alcoholism: are there gender-specific differences?	DRD2 DRD3	1.68e-05	2	143	2	14628173
Pubmed	Comparative studies of molecular mechanisms of dopamine D2 and D3 receptors for the activation of extracellular signal-regulated kinase.	DRD2 DRD3	1.68e-05	2	143	2	15102843
Pubmed	The role of bile acid retention and a common polymorphism in the ABCB11 gene as host factors affecting antiviral treatment response in chronic hepatitis C.	ABCB11 IFNL3	1.68e-05	2	143	2	20723035
Pubmed	Exploring personality traits related to dopamine D2/3 receptor availability in striatal subregions of humans.	DRD2 DRD3	1.68e-05	2	143	2	26944295
Pubmed	Dopamine Receptor Signaling in MIN6 β-Cells Revealed by Fluorescence Fluctuation Spectroscopy.	DRD2 DRD3	1.68e-05	2	143	2	27508444
Pubmed	Effects of smoking on D₂/D₃ striatal receptor availability in alcoholics and social drinkers.	DRD2 DRD3	1.68e-05	2	143	2	23649848
Pubmed	Chimeric D2/D3 dopamine receptors efficiently inhibit adenylyl cyclase in HEK 293 cells.	DRD2 DRD3	1.68e-05	2	143	2	8666994
Pubmed	Association of variants in DRD2 and GRM3 with motor and cognitive function in first-episode psychosis.	DRD2 GRM3	1.68e-05	2	143	2	24682224
Pubmed	NME3 binds to phosphatidic acid and mediates PLD6-induced mitochondrial tethering.	PLD6 NME3	1.68e-05	2	143	2	37584589
Pubmed	[11 C]raclopride positron emission tomography study of dopamine-D2/3 receptor binding in patients with severe major depressive episodes before and after electroconvulsive therapy and compared to control subjects.	DRD2 DRD3	1.68e-05	2	143	2	31943514
Pubmed	Examining the Effects of Sodium Ions on the Binding of Antagonists to Dopamine D2 and D3 Receptors.	DRD2 DRD3	1.68e-05	2	143	2	27379794
Pubmed	Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosis.	DRD2 DRD3	1.68e-05	2	143	2	22591910
Pubmed	In vivo mesolimbic D2/3 receptor binding predicts posttherapeutic clinical responses in restless legs syndrome: a positron emission tomography study.	DRD2 DRD3	1.68e-05	2	143	2	22234337
Pubmed	Up-regulation of dopamine D(2)L mRNA levels in the ventral tegmental area and dorsal striatum of amphetamine-sensitized C57BL/6 mice: role of Ca(v)1.3 L-type Ca(2+) channels.	CACNA1D DRD2	1.68e-05	2	143	2	17026527
Pubmed	Association between DRD2 and DRD3 gene polymorphisms and gastrointestinal symptoms induced by levodopa therapy in Parkinson's disease.	DRD2 DRD3	1.68e-05	2	143	2	27779245
Pubmed	No association of dopamine receptor sensitivity in vivo with genetic predisposition for alcoholism and DRD2/DRD3 gene polymorphisms in alcohol dependence.	DRD2 DRD3	1.68e-05	2	143	2	16759339
Pubmed	-141C Ins/Del polymorphism of the dopamine D2 receptor gene is associated with schizophrenia in a Spanish population.	DRD2 DRD3	1.68e-05	2	143	2	18496209
Pubmed	The effect of haloperidol on D2 dopamine receptor subtype mRNA levels in the brain.	DRD2 DRD3	1.68e-05	2	143	2	8313980
Pubmed	Association of dopamine D2/3 receptor binding potential measured using PET and [11C]-(+)-PHNO with post-mortem DRD2/3 gene expression in the human brain.	DRD2 DRD3	1.68e-05	2	143	2	32818617
Pubmed	The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors.	DRD2 DRD3	1.68e-05	2	143	2	29337986
Pubmed	Evidence that sleep deprivation downregulates dopamine D2R in ventral striatum in the human brain.	DRD2 DRD3	1.68e-05	2	143	2	22573693
Pubmed	New roles for dopamine D2 and D3 receptors in pancreatic beta cell insulin secretion.	DRD2 DRD3	1.68e-05	2	143	2	30626912
Pubmed	D2/D3 dopamine receptor binding with [F-18]fallypride correlates of executive function in medication-naïve patients with schizophrenia.	DRD2 DRD3	1.68e-05	2	143	2	28576546
Pubmed	Cigarette Use and Striatal Dopamine D2/3 Receptors: Possible Role in the Link between Smoking and Nicotine Dependence.	DRD2 DRD3	1.68e-05	2	143	2	27634830
Pubmed	Contribution of functional dopamine D2 and D3 receptor variants to motor and non-motor symptoms of early onset Parkinson's disease.	DRD2 DRD3	1.68e-05	2	143	2	33039854
Pubmed	Activity, non-selective attention and emotionality in dopamine D2/D3 receptor knock-out mice.	DRD2 DRD3	1.68e-05	2	143	2	11864730
Pubmed	A preliminary study of dopamine D2/3 receptor availability and social status in healthy and cocaine dependent humans imaged with [(11)C](+)PHNO.	DRD2 DRD3	1.68e-05	2	143	2	26164205
Pubmed	D3 dopamine autoreceptors do not activate G-protein-gated inwardly rectifying potassium channel currents in substantia nigra dopamine neurons.	DRD3 KCNJ6	1.68e-05	2	143	2	12843272
Pubmed	Dopamine D2/D3 receptor stimulation fails to promote dopaminergic neurogenesis of murine and human midbrain-derived neural precursor cells in vitro.	DRD2 DRD3	1.68e-05	2	143	2	17784836
Pubmed	Exploring regulation and function of dopamine D3 receptors in alcohol use disorder. A PET [11C]-(+)-PHNO study.	DRD2 DRD3	1.68e-05	2	143	2	34349232
Pubmed	Pharmacological characterization of 2-methoxy-N-propylnorapomorphine's interactions with D2 and D3 dopamine receptors.	DRD2 DRD3	1.68e-05	2	143	2	19217026
Pubmed	Early expression of D3 dopamine receptors in murine embryonic development.	DRD2 DRD3	1.68e-05	2	143	2	8601467
Pubmed	Reviews in molecular biology and biotechnology: transmembrane signaling by G protein-coupled receptors.	DRD2 DRD3 HTR6 CHRM3 ADORA2B ADRA2C LPAR6	2.02e-05	200	143	7	18240029
Pubmed	Systematic protein-protein interaction mapping for clinically relevant human GPCRs.	SPNS1 DRD2 HTR6 SLC2A8 PAQR6 SLC18B1 CHRM3 PDIA6 TM9SF2 KCNJ6 SMO MFSD10	3.33e-05	697	143	12	28298427
Pubmed	Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum.	DRD2 DRD3	5.02e-05	3	143	2	18644790
Pubmed	Association of functional variants in the dopamine D2-like receptors with risk for gambling behaviour in healthy Caucasian subjects.	DRD2 DRD3	5.02e-05	3	143	2	20452395
Pubmed	Association of dopamine D(3) receptors with actin-binding protein 280 (ABP-280).	DRD2 DRD3	5.02e-05	3	143	2	11911837
Pubmed	Association between dopamine receptor gene polymorphisms and effects of risperidone treatment: A systematic review and meta-analysis.	DRD2 DRD3	5.02e-05	3	143	2	30103286
Pubmed	Specific V gene usage in anti-phosphorylcholine IgE antibodies.	IGLV7-46 IGLV7-43	5.02e-05	3	143	2	8247027
Pubmed	Restricted immunoglobulin variable region (Ig V) gene expression accompanies secondary rearrangements of light chain Ig V genes in mouse plasmacytomas.	IGLV7-46 IGLV7-43	5.02e-05	3	143	2	10562316
GeneFamily	Olfactory receptors, family 10	OR10J6P OR10Q1 OR10T2 OR10R2 OR10AG1 OR10S1	2.68e-06	66	108	6	157
GeneFamily	Solute carriers	SLC16A9 SLC2A8 SLC30A3 SLC7A11 SLC18B1 SLC22A18 SLC15A2 SLC45A2 SLC24A1 SLC23A2 SLC4A5	2.44e-05	395	108	11	752
GeneFamily	Dopamine receptors	DRD2 DRD3	3.49e-04	5	108	2	181
GeneFamily	Olfactory receptors, family 2	OR2L8 OR2B2 OR2L5 OR2H1 OR2L2	5.83e-04	113	108	5	149
GeneFamily	G protein-coupled receptors, Class A orphans	GPR32 GPR42 MRGPRE GPR119	1.22e-03	78	108	4	262
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	EPHA6 GRM3 SLC7A11 ADORA2B SLC15A2 ABCB11 SPARCL1	3.87e-06	200	143	7	d0812817ef99608994193787a62d39adeb2070ca
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	EPHA6 GRM3 SLC7A11 ADORA2B SLC15A2 ABCB11 SPARCL1	3.87e-06	200	143	7	cd54ddf1919c98e84b7e4aba85b374fc8b407206
Drug	Olanzapine	DRD2 DRD3 HTR6 CHRM3 ADRA2C	3.67e-07	25	138	5	DB00334
Drug	Ziprasidone	DRD2 DRD3 HTR6 CHRM3 ADRA2C	3.67e-07	25	138	5	DB00246
Drug	Aripiprazole	DRD2 DRD3 HTR6 CHRM3 ADRA2C	3.67e-07	25	138	5	DB01238
Drug	Clozapine	DRD2 DRD3 HTR6 CHRM3 ADRA2C	4.52e-07	26	138	5	DB00363
Drug	Quetiapine	DRD2 DRD3 HTR6 CHRM3 ADRA2C	4.52e-07	26	138	5	DB01224
Drug	bifeprunox	DRD2 DRD3 HTR6 KCNJ6	8.85e-07	13	138	4	CID000208951
Drug	promazine	DRD2 DRD3 HTR6 CHRM3 SLC45A2	2.84e-06	37	138	5	CID000004926
Drug	PGW5 compound	DRD2 DRD3 HTR6 CHRM3	2.89e-06	17	138	4	ctd:C000593032
Drug	Methotrimeprazine	DRD2 DRD3 CHRM3 ADRA2C	4.67e-06	19	138	4	DB01403
Drug	bromperidol	DRD2 DRD3 CHRM3 SLC45A2	5.81e-06	20	138	4	CID000002448
Drug	pimozide	CACNA1D DRD2 DRD3 HTR6 CHRM3 CACNG3 KCNJ6	1.26e-05	127	138	7	CID000016362
Drug	paraxanthine	DRD2 NAIP ADORA2B KCNJ6 SLC45A2	1.73e-05	53	138	5	CID000004687
Drug	T15550	DRD2 DRD3 HTR6 CHRM3	1.74e-05	26	138	4	CID000005454
Drug	oxybutynin	DRD2 CHRM3 ABCB11	1.78e-05	9	138	3	ctd:C005419
Drug	Rilapinum	DRD2 HTR6 CHRM3	1.78e-05	9	138	3	CID006446980
Drug	fluperlapine	DRD2 DRD3 HTR6 CHRM3	2.03e-05	27	138	4	CID000049381
Drug	Yohimbine	DRD2 DRD3 ADRA2C	2.53e-05	10	138	3	DB01392
Drug	tenilapine	DRD2 HTR6 CHRM3	2.53e-05	10	138	3	CID006450478
Drug	Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A	MAN2C1 SRCAP CHRM3 ADRA2C NFRKB WDFY3 SLC24A1 SLC23A2	2.67e-05	196	138	8	5438_DN
Drug	xanomeline	DRD2 DRD3 HTR6 CHRM3	3.58e-05	31	138	4	CID000060809
Drug	Sulpiride	DRD2 DRD3	3.65e-05	2	138	2	DB00391
Drug	N-n-propyl-N-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride	DRD2 DRD3	3.65e-05	2	138	2	ctd:C016868
Drug	5-methoxy-1-methyl-2-(n-propylamino)tetralin	DRD2 DRD3	3.65e-05	2	138	2	ctd:C051171
Drug	CGS 15855A	DRD2 DRD3	3.65e-05	2	138	2	ctd:C051347
Drug	(5,6-dimethoxyindan-2-yl)dipropylamine	DRD2 DRD3	3.65e-05	2	138	2	ctd:C086335
Drug	Domperidone	DRD2 DRD3	3.65e-05	2	138	2	DB01184
Drug	UH 232	DRD2 DRD3	3.65e-05	2	138	2	ctd:C045971
Drug	4,4a,5,6,7,8,8a,9-octahydro-5-propyl-1H-pyrzolo(3,4-g)quinoline	DRD2 DRD3	3.65e-05	2	138	2	ctd:C416545
Drug	3-(3-cyanophenyl)-N-n-propylpiperidine	DRD2 DRD3	3.65e-05	2	138	2	ctd:C094012
Drug	iodosulpride	DRD2 DRD3	3.65e-05	2	138	2	ctd:C045105
Drug	fluoroclebopride	DRD2 DRD3	3.65e-05	2	138	2	ctd:C083673
Drug	GR 218231	DRD2 DRD3	3.65e-05	2	138	2	ctd:C408390
Drug	N-(4-(2-(4-(3-cyano-5-trifluoromethylphenyl)piperazin-1-yl)ethyl)cyclohexyl)-3-pyridinesulfonic amide	DRD2 DRD3	3.65e-05	2	138	2	ctd:C539157
Drug	Piribedil	DRD2 DRD3	3.65e-05	2	138	2	ctd:D010891
Drug	AC1L31N6	DRD2 DRD3	3.65e-05	2	138	2	CID000132830
Drug	songorine	STK36 DRD2	3.65e-05	2	138	2	CID000120706
Drug	octoclothepin	DRD2 DRD3 HTR6	4.61e-05	12	138	3	CID000001238
Drug	Chlorprothixene	DRD2 DRD3 CHRM3	4.61e-05	12	138	3	DB01239
Drug	mesoridazine	DRD2 DRD3 HTR6 CHRM3	4.61e-05	33	138	4	CID000004078
Drug	DCG-IV	GRM3 SLC30A3 ADORA2B KCNJ6 ART5	5.84e-05	68	138	5	CID000115114
Drug	diphenidol	DRD2 DRD3 CHRM3	5.96e-05	13	138	3	CID000003055
Drug	molindone	DRD2 DRD3 HTR6 CHRM3	6.55e-05	36	138	4	CID000023897
Drug	benzotropine mesylate	DRD2 DRD3 HTR6 CHRM3	7.31e-05	37	138	4	CID000002344
Drug	Lisuride	DRD2 DRD3 ADRA2C	7.55e-05	14	138	3	DB00589
Drug	Pramipexole	DRD2 DRD3 ADRA2C	7.55e-05	14	138	3	DB00413
Drug	Ropinirole	DRD2 DRD3 ADRA2C	7.55e-05	14	138	3	DB00268
Drug	Risperidone	DRD2 DRD3 ADRA2C	7.55e-05	14	138	3	DB00734
Drug	citalopram	CACNA1D DRD2 DRD3 TFAP2D HTR6 KCNJ6	9.22e-05	120	138	6	CID000002771
Drug	Cabergoline	DRD2 DRD3 ADRA2C	9.40e-05	15	138	3	DB00248
Drug	Apomorphine	DRD2 DRD3 ADRA2C	9.40e-05	15	138	3	DB00714
Drug	OPC-4392	DRD2 DRD3 HTR6	9.40e-05	15	138	3	CID000163839
Drug	aripiprazole	DRD2 DRD3 HTR6 CHRM3 KCNJ6	9.95e-05	76	138	5	CID000060795
Drug	(1-(2-(bis(4-fluorophenyl)methoxy)ethyl)-4-(3-hydroxy-3-phenylpropyl) piperazinyl decanoate)	DRD2 DRD3	1.09e-04	3	138	2	ctd:C461261
Drug	DP-6OH-3CA	DRD2 DRD3	1.09e-04	3	138	2	CID000086146
Drug	Neuriplege	DRD2 DRD3	1.09e-04	3	138	2	CID000065750
Drug	7-(N,N-dipropylamino)-5,6,7,8-tetrahydronaphtho(2,3-b)dihydro-2,3-furan	DRD2 DRD3	1.09e-04	3	138	2	ctd:C090812
Drug	fecapentaene-12	CHUK SDHA	1.09e-04	3	138	2	CID006437067
Drug	7-hydroxy-2-N,N-dipropylaminotetralin	DRD2 DRD3	1.09e-04	3	138	2	ctd:C031349
Drug	3-N-methylspiperone	DRD2 DRD3	1.09e-04	3	138	2	ctd:C039167
Drug	quinelorane	DRD2 DRD3	1.09e-04	3	138	2	ctd:C047726
Drug	FLA908	DRD2 DRD3	1.09e-04	3	138	2	CID000129516
Drug	SB-277011	DRD2 DRD3	1.09e-04	3	138	2	CID005311096
Drug	DCHAPS	DRD2 DRD3	1.09e-04	3	138	2	CID000129392
Drug	nafadotride	DRD2 DRD3	1.09e-04	3	138	2	ctd:C097285
Drug	BP 897	DRD2 DRD3	1.09e-04	3	138	2	ctd:C120565
Drug	iodoethylspiperone	DRD2 DRD3	1.09e-04	3	138	2	CID000131222
Drug	Saphris	DRD2 DRD3 HTR6 CHRM3	1.10e-04	41	138	4	CID000163091
Drug	clonidine	DRD2 DRD3 HTR6 COX8A ADORA2B LPAR6 KCNJ6 ART5	1.11e-04	240	138	8	CID000002803
Drug	quinolinic acid	DRD2 DRD3 GRM3 ADORA2B LIFR NUDT6 SLC23A2	1.13e-04	179	138	7	CID000001066
Drug	AC1N8H7N	ABCC4 TNPO2 KCNJ6 ABCB11 SLC45A2	1.13e-04	78	138	5	CID004318740
Drug	thioridazine	DRD2 DRD3 HTR6 CHRM3 KCNJ6	1.20e-04	79	138	5	CID000005452
Drug	Paliperidone	DRD2 DRD3 ADRA2C	1.39e-04	17	138	3	DB01267
Drug	Pergolide	DRD2 DRD3 ADRA2C	1.39e-04	17	138	3	DB01186
Drug	Bromocriptine	DRD2 DRD3 ADRA2C	1.66e-04	18	138	3	DB01200
Drug	baclofen	CACNA1D DRD2 DRD3 GRM3 ADORA2B KCNJ6 ART5	1.68e-04	191	138	7	CID000002284
Drug	loxapine	DRD2 DRD3 HTR6 CHRM3	1.73e-04	46	138	4	CID000003964
Drug	chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A	PAQR6 SLC30A3 CHRM3 SBF1 NFRKB SLC24A1 SLC23A2	1.91e-04	195	138	7	6977_UP
Drug	RP 62203	DRD2 DRD3 HTR6	1.97e-04	19	138	3	CID000060785
Drug	haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A	SLC30A3 SLC7A11 CHRM3 OPRPN SBF1 WDFY3 TMC5	2.03e-04	197	138	7	7003_UP
Drug	aspirin, USP; Up 200; 100uM; HL60; HT_HG-U133A	PECR DRD2 ISOC1 SLC7A11 PCNX2 SLC22A18 WDFY3	2.10e-04	198	138	7	1145_UP
Drug	idazoxan	DRD2 DRD3 HTR6 ADORA2B ART5	2.10e-04	89	138	5	CID000054459
Drug	clofluperol	DRD2 DRD3	2.17e-04	4	138	2	CID000025293
Drug	Pimozide	DRD2 DRD3	2.17e-04	4	138	2	DB01100
Drug	NCQ-469	DRD2 DRD3	2.17e-04	4	138	2	CID000127915
Drug	spectramide	DRD2 DRD3	2.17e-04	4	138	2	CID000130377
Drug	Amisulpride	DRD2 DRD3	2.17e-04	4	138	2	DB06288
Drug	sarizotan	DRD2 DRD3	2.17e-04	4	138	2	ctd:C443959
Drug	Cinnarizine	DRD2 ABCB11	2.17e-04	4	138	2	ctd:D002936
Drug	3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol	DRD2 DRD3	2.17e-04	4	138	2	ctd:C062458
Drug	SKF83959	DRD2 DRD3	2.17e-04	4	138	2	CID000133538
Drug	zotepine	DRD2 DRD3 HTR6 CHRM3	2.22e-04	49	138	4	CID000005736
Drug	Doxepin	DRD2 CHRM3 ADRA2C	2.30e-04	20	138	3	DB01142
Drug	Baclofen	ABCC4 DRD3 KCNJ6	2.30e-04	20	138	3	ctd:D001418
Drug	LY 171555	DRD2 DRD3 GRM3 ADORA2B KCNJ6 ART5	2.32e-04	142	138	6	CID000001257
Drug	sertindole	DRD2 DRD3 HTR6 CHRM3	2.40e-04	50	138	4	CID000060149
Drug	perlapine	DRD2 DRD3 HTR6	2.67e-04	21	138	3	CID000016106
Drug	AC1L3NFS	MAN2C1 NPC1L1 SLC45A2	2.67e-04	21	138	3	CID000092111
Drug	perphenazine	DRD2 DRD3 HTR6 CHRM3	3.00e-04	53	138	4	CID000004748
Drug	setoperone	DRD2 DRD3 HTR6	3.08e-04	22	138	3	CID000068604
Drug	AC1L1V2E	HTR6 CHUK SDHA	3.08e-04	22	138	3	CID000010376
Disease	Disruptive, Impulse Control, and Conduct Disorders	DRD2 DRD3	5.24e-05	3	124	2	C0021122
Disease	Intermittent Explosive Disorder	DRD2 DRD3	5.24e-05	3	124	2	C0021776
Disease	Mood Disorders	CACNA1D DRD2 DRD3 HTR6 GRM3 ADRA2C	7.99e-05	168	124	6	C0525045
Disease	heroin dependence (biomarker_via_orthology)	DRD2 DRD3	1.74e-04	5	124	2	DOID:9976 (biomarker_via_orthology)
Disease	Cognition Disorders	ABCC4 DRD2 DRD3	5.49e-04	38	124	3	C0009241
Disease	cystic fibrosis (implicated_via_orthology)	ABCC4 ABCB11	6.19e-04	9	124	2	DOID:1485 (implicated_via_orthology)
Disease	Recurrent depression	DRD2 DRD3	6.19e-04	9	124	2	C0221480
Disease	Delirium	DRD2 DRD3	7.71e-04	10	124	2	C0011206
Disease	Gastrointestinal Stromal Sarcoma	STK36 SMO SDHA	1.03e-03	47	124	3	C3179349
Disease	Lenticulostriate Disorders	DRD2 DRD3	1.12e-03	12	124	2	C0750951
Disease	Extrapyramidal Disorders	DRD2 DRD3	1.12e-03	12	124	2	C0015371
Disease	nicotine dependence (implicated_via_orthology)	DRD2 DRD3	1.12e-03	12	124	2	DOID:0050742 (implicated_via_orthology)
Disease	Basal Ganglia Diseases	DRD2 DRD3	1.12e-03	12	124	2	C0004782
Disease	Gastrointestinal Stromal Tumors	STK36 SMO SDHA	1.23e-03	50	124	3	C0238198
Disease	Drug habituation	ABCC4 DRD2 CSMD3 SLC45A2	1.43e-03	115	124	4	C0013170
Disease	Drug abuse	ABCC4 DRD2 CSMD3 SLC45A2	1.43e-03	115	124	4	C0013146
Disease	Prescription Drug Abuse	ABCC4 DRD2 CSMD3 SLC45A2	1.43e-03	115	124	4	C4316881
Disease	Substance-Related Disorders	ABCC4 DRD2 CSMD3 SLC45A2	1.43e-03	115	124	4	C0236969
Disease	Drug Use Disorders	ABCC4 DRD2 CSMD3 SLC45A2	1.43e-03	115	124	4	C0013222
Disease	Drug Dependence	ABCC4 DRD2 CSMD3 SLC45A2	1.43e-03	115	124	4	C1510472
Disease	Substance Dependence	ABCC4 DRD2 CSMD3 SLC45A2	1.43e-03	115	124	4	C0038580
Disease	Substance Use Disorders	ABCC4 DRD2 CSMD3 SLC45A2	1.43e-03	115	124	4	C0038586
Disease	Organic Mental Disorders, Substance-Induced	ABCC4 DRD2 CSMD3 SLC45A2	1.43e-03	115	124	4	C0029231
Disease	Substance abuse problem	ABCC4 DRD2 CSMD3 SLC45A2	1.48e-03	116	124	4	C0740858
Disease	Dyskinesia, Medication-Induced	DRD2 DRD3	1.77e-03	15	124	2	C0751088
Disease	Dyskinesia, Drug-Induced	DRD2 DRD3	1.77e-03	15	124	2	C0013386
Disease	ureidopropionic acid measurement	ARL4A OTOG	2.02e-03	16	124	2	EFO_0010542
Disease	pancreatic ductal carcinoma (is_implicated_in)	HEATR1 SMO	2.02e-03	16	124	2	DOID:3587 (is_implicated_in)
Disease	hydrocephalus (implicated_via_orthology)	STK36 HYDIN	2.86e-03	19	124	2	DOID:10908 (implicated_via_orthology)
Disease	electroencephalogram measurement	DNAH3 CMYA5 PCNX2	3.78e-03	74	124	3	EFO_0004357
Disease	Amphetamine-Related Disorders	DRD2 DRD3 HTR6	3.92e-03	75	124	3	C0236733
Disease	Amphetamine Abuse	DRD2 DRD3 HTR6	3.92e-03	75	124	3	C0236807
Disease	Amphetamine Addiction	DRD2 DRD3 HTR6	3.92e-03	75	124	3	C0236804
Disease	carnitine measurement	PECR SLC16A9 RPUSD4	4.07e-03	76	124	3	EFO_0010469
Disease	worry measurement	DRD2 ZDHHC5 GRM3 CHRM3	4.12e-03	154	124	4	EFO_0009589
Disease	Schizophrenia	DRD2 DRD3 HTR6 CMYA5 GRM3 SLC30A3 LIFR DIO3 SDHA IFNL3	4.16e-03	883	124	10	C0036341
Disease	Etat Marbre	DRD2 DRD3	4.18e-03	23	124	2	C0266487

Protein segments in the cluster

Peptide	Gene	Start	Entry
TVAACSPFVLQFLQG	NAIP	876	Q13075
AFSLQDLFPTIASGC	ADGRB2	51	O60241
LLLPFTTTSLCELGF	FAM200B	601	P0CF97
VASGLTFFLPSGAIC	HTR6	191	P50406
SEVSFSCNFPFILVG	CSMD3	3311	Q7Z407
SCNFPFILVGSSTRI	CSMD3	3316	Q7Z407
SLPLFEAFTACGFVQ	CPED1	671	A4D0V7
IPFAITISLGFCTDF	ADORA2B	61	P29275
FPNSFVTLSICSGLR	ADAM18	101	Q9Y3Q7
ILSSCIGSFFAPCLI	ADRA2C	211	P18825
KFISPSSQVFICLGL	GRM3	681	Q14832
SFALGCVNSSLNPFL	GPR32	301	O75388
CFIQFLSEPTITFGT	CHRM3	221	P20309
CPIIASLSFGATRTF	ALKBH3	201	Q96Q83
PSFQSFHIVILGLDC	ARL4A	16	P40617
SVTLLFFGGLCVAAS	CACNG3	111	O60359
SLVILCFFPFLALSG	ABCB11	901	O95342
CFFPFLALSGATQTR	ABCB11	906	O95342
DSVGRVSFPSLVCFL	CAPN13	621	Q6MZZ7
VQPGFCLYLSTTLSL	DNHD1	3716	Q96M86
SVKFNPIETFLLGSC	DCAF13	201	Q9NV06
FGTPAICAALSTFQT	TFAP2D	386	Q7Z6R9
SSTIFLVLPFTGIAC	OR2L2	201	Q8NH16
LIGSAFSVLQFLCAP	MFSD10	91	Q14728
FSVLQFLCAPLTGAT	MFSD10	96	Q14728
LCVSSFGARPVTIFS	SLC16A9	71	Q7RTY1
AFSPCTAQLTGVLLY	OR10S1	251	Q8NGN2
TCQIFLLPFCGTNTI	OR10AG1	151	Q8NH19
TLGNLTPSSTVFFCC	ISOC1	106	Q96CN7
LKPCLGINEISSSFF	NFRKB	366	Q6P4R8
SAVFNILFVIGTCSL	SLC24A1	531	O60721
QTASCLVLFPRFLGT	DIO3	41	P55073
PCVTNLNGFVSAFLF	KCNJ6	131	P48051
LGLISILCFAASTFP	SLC66A1	41	Q6ZP29
SLCTSFVGTLQYLAP	CHUK	176	O15111
QVLSFCILQLFPFTS	ATP9B	621	O43861
QFASTAPLLFNGCRS	DCAF4L1	231	Q3SXM0
NLRSLACQPISFSGF	POLD2	441	P49005
PALFSAFCGLLVALS	PCNX2	1031	A6NKB5
SSTIFLVFPFTGIAC	OR2L5	201	Q8NG80
SATIFLVFPFIGISC	OR2L8	201	Q8NGY9
SSNFLLTAFPGLECA	OR51T1	11	Q8NGJ9
ALSQLAFTVNLPFCG	OR4K3	156	Q96R72
TLSQLSFTVNLPFCG	OR4K5	156	Q8NGD3
TTSQLAFTVNLPFCG	OR4K15	156	Q8NH41
QSRFIAPAASLGFCF	NUDT6	101	P53370
FPFLLSLFCGAISQQ	PCDHGB1	16	Q9Y5G3
FINTTARVPCFLAGD	LPO	356	P22079
SVVCFLLSPAASFIT	PECR	241	Q9BY49
LTSFLLFLSARNCGP	GPR119	301	Q8TDV5
ASTCSFNPGVFVANL	GLT8D1	236	Q68CQ7
FGFRFLSCLPVTADT	LMNTD2	616	Q8IXW0
VGFFIPLILNVTCSS	LPAR6	191	P43657
FDSCIIVLGSPSFLS	MEFV	636	O15553
VVVACVNAASPFLGF	PGAP6	416	Q9HCN3
FFVPAAALNSFLCTG	PAQR6	151	Q6TCH4
FSFCVSPLLVFVNSK	DGKH	326	Q86XP1
LLLSGACTQFFGEPS	MRGPRE	156	Q86SM8
AVTVLGSLVCFPNTY	RALGAPA2	1101	Q2PPJ7
LVAATLLNFLVCFGP	GPR42	226	O15529
LFLFLLTCCPGSNSQ	IGLV7-43	6	P04211
CTFLSGFLLLAGTQD	PAAF1	286	Q9BRP4
FAIFCNASTALGPLE	PKD1L2	791	Q7Z442
QSSGFTPVFLQFLDC	SBF1	1476	O95248
ATGFFIALVATNLIC	OR10T2	151	Q8NGX3
QEIFSSPACLTGSFL	HERC5	416	Q9UII4
ILLPLQSCFGKLFSS	ABCC4	246	O15439
SLSEAICFFLGALTP	NPC1L1	751	Q9UHC9
TNLVISQGPFLYCSL	CDC45	436	O75419
NLLLSTSGPFFICET	HYDIN	1086	Q4G0P3
TFIFEGTELSLNPTC	DNAH3	1511	Q8TD57
TITCLFNDIPGFSLL	C3orf20	406	Q8ND61
VNFTGCSLPSERAIF	CMYA5	3786	Q8N3K9
SPGCLEASVTFNLFR	IFNL3	166	Q8IZI9
SASIALPLFFCAGLA	TMEM30B	31	Q3MIR4
SIFCSLPLGFFIVSS	GK	531	P32189
IFLTFVFTVSCGPSV	DEFB113	6	Q30KQ7
FGASCPVAVLSSFLT	MAN2C1	36	Q9NTJ4
AVGLTSCFVTFLLPA	COX8A	41	P10176
CLQALSGVASPFYLI	HEATR1	941	Q9H583
VLSFTISCPLLFGLN	DRD2	161	P14416
TICGSNYPLSIAFIV	SLC15A2	36	Q16348
GLFPNVYSTLVLCSL	SLC45A2	416	Q9UMX9
TFPQAVLLLFRCATG	CACNA1D	1391	Q01668
LFLFLLTCCPGSNSQ	IGLV7-46	6	A0A075B6I9
AFAVSCPLLFGFNTT	DRD3	161	P35462
SFGSPCSINSRQFLI	LIFR	1056	P42702
LAVGFLPFLTSVTLC	LINGO4	536	Q6UY18
LGLVSCTFFLAVNGL	PDIA6	6	Q15084
LSPGFVTALRALSFC	PTX4	286	Q96A99
GCVAQLFIFLALGST	OR2B2	96	Q9GZK3
LTIFANLFPAACTGA	NME3	6	Q13232
NVSCLFTFPNGTTSL	OTOG	2761	Q6ZRI0
CALVTGPYVISFINS	OR8H1	141	Q8NGG4
AFCPSFLRAGFLNSI	EPHA6	711	Q9UF33
PISLAGCTTQTFFFV	OR10J6P	91	Q8NGY7
LQLTALIFTLPFCGH	OR10Q1	161	Q8NGQ4
SLTVVNLVFSLPFCS	OR10R2	176	Q8NGX6
SFLGCSVQLFIFLSL	OR2H1	91	Q9GZK4
SFLGCVSQVFLLLSS	OR14A16	91	Q8NHC5
LFPLLGLSCSSTYIN	OR8G3P	181	P0DMU2
LCLFAFSSPQLGRAV	PLD6	96	Q8N2A8
GSLFTLVSKPFCAAA	RPUSD4	21	Q96CM3
TLGNLVPFTLTLLCF	TAS2R31	181	P59538
LTAAQIFGLLFASCQ	UTP20	2481	O75691
LVFVFLGNSSCAPQR	SPX	16	Q9BT56
LTLISGFFCTLAPSV	TMEM178B	261	H3BS89
GFCASFLLGSVLNVL	PKDCC	11	Q504Y2
SEAGFNTACVTKLFP	SDHA	81	P31040
SLSSCFGFLDPTLSL	SLC18B1	246	Q6NT16
FIFSTGLCALPVLTQ	IGLV4-3	11	A0A075B6K6
LLCSVPFVAGFAVIT	SLC2A8	101	Q9NY64
CFELTTFSFRGNPIS	PRAMEF20	376	Q5VT98
ARFFLSTLPASGECQ	SIM2	476	Q14190
FLGLLALISCFTPSE	OPRPN	6	Q99935
FTPSQVGCLFTFLAR	VPS8	826	Q8N3P4
FITPGICFSTASLVL	SRCAP	916	Q6ZRS2
TLLGAVLSFTCIPAS	SLC22A18	191	Q96BI1
SSVFHFCLLVPGLVF	SLC22A18	326	Q96BI1
STISPCFKNFLQGLL	STK36	221	Q9NRP7
FSSVIAPTLLCGFLF	ASPRV1	56	Q53RT3
SFGEISVLLQVPFTC	CNBD1	401	Q8NA66
SVLRGFCANSSLAFP	CHST12	126	Q9NRB3
SLAVPIFVALSCFGS	SLC7A11	316	Q9UPY5
SCIFLSPGTRAAFEQ	SEMA6B	551	Q9H3T3
PITTASFIAAGICFN	TMEM128	121	Q5BJH2
TAIPSELFSSFVNCL	XPO4	361	Q9C0E2
FGQFISSTLPTFAVC	WDFY3	1586	Q8IZQ1
SPFFLLLSLFLGTCA	TMTC1	201	Q8IUR5
LTCFSGTIAVPFLLA	SLC23A2	111	Q9UGH3
TTFGCRLPLFQASAF	SLC23A2	156	Q9UGH3
LDVSCNSISFVAPGF	TLR9	706	Q9NR96
FFLCLLGTAAAIPTN	SPARCL1	6	Q14515
SAPFLFLSLACARGS	SPNS1	366	Q9H2V7
FVGCIFTAELSTPFV	TLCD3A	146	Q8TBR7
CLSSVATALQSGFLP	TNPO2	586	O14787
RCALFSGPLVQAVSA	TLNRD1	246	Q9H1K6
LFCLFSGQPLIILSS	SLC4A5	566	Q9BY07
AFGAVTGLCTLFTLA	SMO	236	Q99835
DPISTFLFSICALGS	SLC30A3	266	Q99726
FLFSICALGSTAPTL	SLC30A3	271	Q99726
GATTLFFAFTCPGLS	ZDHHC5	26	Q9C0B5
VTLFFACLGFLSPAN	TM9SF2	381	Q99805
FFPSFTGVLCTLAIT	TMC5	841	Q6UXY8
FSSILVPGFFLLACI	PIEZO1	681	Q92508
TCAFAPNTLLLATGS	WDSUB1	286	Q8N9V3
ISRGFTLVSAACPFN	VEZT	231	Q9HBM0
VPLSVFRAGTLTCFV	TPGS1	176	Q6ZTW0
LCLGKAPSSSQLFLF	USP40	831	Q9NVE5
NATLFSLTTCFGAPI	ART5	196	Q96L15
SLTTCFGAPIQAFSV	ART5	201	Q96L15